Search

everythinglearnresearchcommunity

for

Search:↓

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Sebaceous glands age due to genetic and environmental factors, affecting sebum production and composition.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Nanoemulgels could effectively treat skin diseases and may replace or complement current therapies.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Angelica sinensis and Tetrapanax papyrifer are common in Taiwanese TCM for lactation, with potential anticancer benefits.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Nanocosmetics with natural extracts offer benefits but need more research on safety and environmental impact.

Nivolumab can cause hair loss as a rare side effect.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Peperomia pellucida is safe to eat and has strong antioxidant benefits.

Some antiseizure medications can cause cosmetic problems like hair loss, excessive hair growth, acne, and gum overgrowth.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Avacopan may cause unexpected side effects, so early monitoring is important.

Hair loss in alopecia areata can negatively affect sexual quality of life.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Stem cells have great potential for treating various medical conditions.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.